- Home
- MREO vs SUUN Comparison
MREO vs SUUN Comparison
Compare MREO & SUUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MREO | SUUN |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 61.2M |
| IPO Year | 2017 | 2024 |
Fundamental Metrics
Financial Performance| Metric | MREO | SUUN |
|---|---|---|
| Price | $0.33 | $0.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $1.50 | ★ $3.00 |
| AVG Volume (30 Days) | ★ 1.4M | 476.6K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,000.00 | N/A |
| Revenue This Year | $6,000.20 | $112.68 |
| Revenue Next Year | $34.71 | $1.75 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $0.45 |
| 52 Week High | $2.94 | $2.55 |
Technical Indicators
Market Signals| Indicator | MREO | SUUN |
|---|---|---|
| Relative Strength Index (RSI) | 40.25 | 44.96 |
| Support Level | $0.32 | $0.45 |
| Resistance Level | $0.42 | $0.71 |
| Average True Range (ATR) | 0.02 | 0.06 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 29.29 | 67.75 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About SUUN SolarBank Corporation
PowerBank Corp is an independent renewable and clean energy project developer, power producer, and asset operator in Canada and the United States, with the majority of its revenue coming from the United States. The Company operates through two reportable segments: Development and EPC, which involves the development and construction of solar photovoltaic power projects, and IPP Production, which includes the operation of solar power and battery energy storage systems. Corporate and other activities cover operation, maintenance, and repairs. The majority of revenue is generated from the Development and EPC segment.